07/22/2024 8:44 AM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 8:54 AM | Collard Craig A (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 8:32 AM | Duarte Ira (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:44 AM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/18/2024 3:43 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 1:21 PM | Duarte Ira (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 8:34 AM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/31/2024 10:08 AM | Heron Therapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
05/29/2024 7:05 AM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:05 AM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:05 AM | Heron Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 1:33 PM | Heron Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024 1:36 PM | Heron Therapeutics (Filer)
| Form ARS | |
04/19/2024 4:48 PM | Duarte Ira (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:02 PM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:21 PM | Heron Therapeutics (Filer)
| Form PRE 14A | |
04/19/2024 3:34 PM | Collard Craig A (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:32 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:46 AM | Deep Track Capital, LP (Filed by) Heron Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024 10:43 AM | FRANKLIN RESOURCES INC (Filed by) Heron Therapeutics (Subject)
| Form SC 13G/A | |
01/24/2024 7:01 AM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 7:58 PM | Collard Craig A (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:00 PM | Duarte Ira (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:01 PM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:01 PM | Heron Therapeutics (Issuer) Peraza Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:02 PM | Dissanaike Sharmila (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:03 PM | Heron Therapeutics (Issuer) Johnson Craig A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:04 PM | Heron Therapeutics (Issuer) Morgan Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:04 PM | Heron Therapeutics (Issuer) Rodriguez Susan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 8:05 PM | Christian Waage (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 4:19 PM | Heron Therapeutics (Issuer) Peraza Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:07 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 3:30 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 4:25 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 1:45 PM | Heron Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
12/06/2023 3:47 PM | BlackRock Inc. (Filed by) Heron Therapeutics (Subject)
| Form SC 13G/A | |
11/21/2023 11:19 AM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 9:07 AM | Forbes William P (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 11:36 AM | Duarte Ira (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 11:37 AM | Collard Craig A (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 3:10 PM | Heron Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year"
At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains."![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8720&Placement=NativeDisplay&Source=NativeDisplay) Click here now to watch this exclusive interview |
10/17/2023 6:57 PM | Heron Therapeutics (Issuer) Peraza Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 8:14 PM | Heron Therapeutics (Filer)
| Form 424B3 | |
08/31/2023 11:15 PM | Heron Therapeutics (Filer)
| Form EFFECT | |
08/24/2023 3:09 PM | Collard Craig A (Reporting) Heron Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2023 12:56 PM | Heron Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |